ClinConnect ClinConnect Logo
Search / Trial NCT05005858

Modified Ridge Splitting Technique Using Autogenous Bone Blocks (MRS)

Launched by SEMMELWEIS UNIVERSITY · Aug 10, 2021

Trial Information

Current as of June 28, 2025

Unknown status

Keywords

ClinConnect Summary

Patients were required to rinse with a 0.2% chlorhexidine solution for 1 min before surgery. Under local anesthesia, a full-thickness flap was raised from a crestal incision with a mesial releasing incision to access the alveolar ridge and the retromolar area. A midcrestal osteotomy was preformed, leaving a safety zone of at least 2 mm from the adjacent tooth. Two vertical releasing osteotomies were performed at the mesial and distal ends of the mid-crestal osteotomy. Apically, the vertical osteotomies were connected horizontally with a superficial corticotomy. Osteotomies and corticotomies...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Mandibular ridge width at least 3 mm;
  • Ridge height at least 11 mm;
  • Spongiosa between the two cortical plates at least 1 mm
  • Exclusion Criteria:
  • History of uncontrolled medical disorders;
  • History of systemic diseases or medication that alter bone metabolism;
  • Poor oral hygiene;
  • Smoking

About Semmelweis University

Semmelweis University, located in Budapest, Hungary, is a prestigious institution renowned for its commitment to advancing medical education, research, and healthcare innovation. As a prominent clinical trial sponsor, the university leverages its extensive expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. With a focus on ethical standards and scientific excellence, Semmelweis University collaborates with a network of healthcare professionals and researchers to translate groundbreaking discoveries into practical applications, ultimately contributing to the global advancement of medical science.

Locations

Budapest, , Hungary

Patients applied

0 patients applied

Trial Officials

Márton Kivovics, Ph.D

Study Director

Semmelweis University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials